* Sabra Health Care REIT Inc SBRA.OQ SBRA.O is expected
to show a rise in quarterly revenue when it reports results on
February 22.
* The Irvine California-based company is expected to report
a
14.7% increase in revenue to $155.556 million from $135.66
million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Sabra Health Care
REIT
Inc is for earnings of 13 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 9
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Sabra
Health Care
REIT Inc is $14, above its last closing price of $13.02.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.37 0.37 0.36 Missed -3.2
Jun. 30 2022 0.38 0.38 0.39 Beat 3.6
Mar. 31 2022 0.38 0.38 0.38 Met -0.7
Dec. 31 2021 0.36 0.37 0.39 Beat 5.7
Sep. 0.39 0.39 0.38 Missed -2.2
30 2021
Jun. 30 2021 0.39 0.39 0.39 Met -1.2
Mar. 31 2021 0.40 0.40 0.40 Met -0.4
Dec. 31 2020 0.44 0.43 0.42 Missed -2.9
This summary was machine generated February 20 at 00:11 GMT.
All figures in US dollars unless otherwise stated